We are live on
!
Find out more
HCM
Highline Capital Management Portfolio holdings
AUM
$53.5M
1-Year Est. Return
21.72%
This Fund
S&P 500
This Quarter
Est. Return
-6.33%
1 Year Est. Return
-21.72%
3 Year Est. Return
+197.64%
5 Year Est. Return
+251.63%
10 Year Est. Return
–
AUM
$685M
AUM Growth
-$681M
(-50%)
Cap. Flow
-$617M
Cap. Flow
% of AUM
-90.09%
Top 10 Holdings %
Top 10 Hldgs %
69.33%
Holding
41
New
9
Increased
–
Reduced
15
Closed
16
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$61.5M |
| 2 |
Salesforce
CRM
|
+$52.8M |
| 3 |
Meta Platforms (Facebook)
META
|
+$51.6M |
| 4 |
Progressive
PGR
|
+$38.2M |
| 5 |
Advanced Micro Devices
AMD
|
+$27.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Elevance Health
ELV
|
+$69.4M |
| 2 |
Royal Caribbean
RCL
|
+$67.5M |
| 3 |
Take-Two Interactive
TTWO
|
+$64.4M |
| 4 |
ArcelorMittal
MT
|
+$56.1M |
| 5 |
CTLT
CATALENT, INC.
CTLT
|
+$53.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 26.77% |
| 2 | Healthcare | 19.19% |
| 3 | Technology | 16.49% |
| 4 | Consumer Staples | 13.81% |
| 5 | Communication Services | 7.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Alibaba
BABA
$269B
| $59.8M | 8.73% |
+357,818
| New | +$61.5M |
|
2
Tyson Foods
TSN
$20.2B
| $52.4M | 7.65% |
608,455
-37,645
| -6% | -$3.2M |
|
|
3
Salesforce
CRM
$134B
| $51.6M | 7.52% |
+347,350
| New | +$52.8M |
|
|
CTLT
4
DELISTED
CATALENT, INC.
CTLT
| $50.3M | 7.34% |
1,055,543
-1,001,166
| -49% | -$53.8M |
|
|
5
Meta Platforms (Facebook)
META
$1.51T
| $48.4M | 7.06% |
+271,575
| New | +$51.6M |
|
6
Caesars Entertainment
CZR
$6.1B
| $46.5M | 6.79% |
1,167,295
-375,550
| -24% | -$15.9M |
|
7
IQVIA
IQV
$34.7B
| $43.6M | 6.36% |
291,901
-268,925
| -48% | -$41.9M |
|
|
SAFM
8
DELISTED
Sanderson Farms Inc
SAFM
| $42.2M | 6.16% |
279,095
-104,850
| -27% | -$15M |
|
|
GRA
9
DELISTED
W.R. Grace & Co.
GRA
| $41.1M | 6% |
615,580
-358,500
| -37% | -$25.1M |
|
10
Commercial Metals
CMC
$7.63B
| $39.2M | 5.72% |
2,254,983
-2,179,025
| -49% | -$37.3M |
|
|
11
Progressive
PGR
$124B
| $37.5M | 5.47% |
+485,200
| New | +$38.2M |
|
|
12
Advanced Micro Devices
AMD
$851B
| $25.6M | 3.74% |
+884,200
| New | +$27.7M |
|
|
MTOR
13
DELISTED
MERITOR, Inc.
MTOR
| $23.3M | 3.39% |
1,257,280
-376,700
| -23% | -$7.63M |
|
14
Corpay
CPAY
$24.2B
| $21.5M | 3.13% |
+74,896
| New | +$21.8M |
|
15
UroGen Pharma
URGN
$2B
| $20.9M | 3.05% |
877,120
-136,958
| -14% | -$4.48M |
|
|
16
CALL
Tyson Foods
TSN
$20.2B
| $15.8M | 2.31% |
+183,900
| New | +$15.6M |
|
17
Workday
WDAY
$33.4B
| $14.3M | 2.09% |
+84,300
| New | +$16.3M |
|
|
FPAC.U
18
DELISTED
Far Point Acquisition Corporation Units, each consisting of one share of Class A common stock, $0.00
FPAC.U
| $13.2M | 1.92% |
1,234,000
-842,099
| -41% | -$9.01M |
|
19
Ultragenyx Pharmaceutical
RARE
$2.65B
| $12.6M | 1.85% |
295,653
-94,800
| -24% | -$5.15M |
|
20
Boyd Gaming
BYD
$6.47B
| $11.1M | 1.62% |
463,304
-1,317,835
| -74% | -$33.3M |
|
21
PUT
Pinduoduo
PDD
$118B
| $5.64M | 0.82% |
175,000
| – | – |
|
22
Alector
ALEC
$164M
| $3.14M | 0.46% |
217,782
-428,000
| -66% | -$7.73M |
|
|
HSACU
23
DELISTED
Health Sciences Acquisitions Corporation Units
HSACU
| $3.01M | 0.44% |
280,371
-19,629
| -7% | -$210K |
|
24
Carvana
CVNA
$43.3B
| $1.66M | 0.24% |
+125,445
| New | +$1.8M |
|
25
Arcturus Therapeutics
ARCT
$157M
| $918K | 0.13% |
89,366
-128,500
| -59% | -$1.39M |
|
Similar funds
NHSP
DTIM
BI
MCAI
PCM
FC
AEPIP
SAM
Highline Capital Management's Q3 2019 Portfolio in Review
As of Q3 2019, Highline Capital Management held 41 positions worth $685M, down 50% from $1.37B the previous quarter. Its ten largest holdings account for 69% of the portfolio.
Highline Capital Management withdrew a net $617M in Q3 2019, closing 16 positions and reducing 15 holdings. Its most notable exit was Elevance Health, an estimated $69.4M position sold in full.
By sector, the portfolio is most concentrated in Consumer Discretionary at 27% of assets, up from 22% a quarter earlier, followed by Healthcare and Technology.
Against the trend, Highline Capital Management opened a new position in Alibaba worth $59.8M.
- Highline Capital Management's largest Q3 2019 buy was Alibaba: 357,818 shares worth $59.8M.
- Highline Capital Management's biggest Q3 2019 reduction was CATALENT, INC., cutting an estimated $53.8M.
- Highline Capital Management fully exited Elevance Health in Q3 2019, selling an estimated $69.4M.
- Highline Capital Management's ten largest holdings make up 69% of its $685M portfolio in Q3 2019.
- Highline Capital Management opened 9 new positions and closed 16 in Q3 2019.
- Highline Capital Management's portfolio value fell 50% quarter-over-quarter to $685M.
Based on Highline Capital Management's 13F filing for Q3 2019, filed 14 Nov 2019.